460 related articles for article (PubMed ID: 2908095)
1. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline.
Seeman P; Guan HC; Nobrega J; Jiwa D; Markstein R; Balk JH; Picetti R; Borrelli E; Van Tol HH
Synapse; 1997 Feb; 25(2):137-46. PubMed ID: 9021894
[TBL] [Abstract][Full Text] [Related]
4. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
Joyce JN; Lexow N; Bird E; Winokur A
Synapse; 1988; 2(5):546-57. PubMed ID: 2973147
[TBL] [Abstract][Full Text] [Related]
5. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
[TBL] [Abstract][Full Text] [Related]
6. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK
Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614
[TBL] [Abstract][Full Text] [Related]
7. Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia.
Pearce RK; Seeman P; Jellinger K; Tourtellotte WW
Eur Neurol; 1990; 30 Suppl 1():9-14. PubMed ID: 2138080
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptors and transporters in Parkinson's disease and schizophrenia.
Seeman P; Niznik HB
FASEB J; 1990 Jul; 4(10):2737-44. PubMed ID: 2197154
[TBL] [Abstract][Full Text] [Related]
9. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
Seeman P; Guan HC; Van Tol HH; Niznik HB
Synapse; 1993 Aug; 14(4):247-53. PubMed ID: 8248849
[TBL] [Abstract][Full Text] [Related]
10. L-dopa reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum.
Guttman M; Seeman P
J Neural Transm; 1985; 64(2):93-103. PubMed ID: 2934514
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptors and the dopamine hypothesis of schizophrenia.
Seeman P
Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
[TBL] [Abstract][Full Text] [Related]
12. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
Seeman P
Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous dopamine receptor changes in early and late Huntington's disease.
Richfield EK; O'Brien CF; Eskin T; Shoulson I
Neurosci Lett; 1991 Oct; 132(1):121-6. PubMed ID: 1838580
[TBL] [Abstract][Full Text] [Related]
14. A post-mortem study on striatal dopamine receptors in Parkinson's disease.
Rinne JO; Laihinen A; Lönnberg P; Marjamäki P; Rinne UK
Brain Res; 1991 Aug; 556(1):117-22. PubMed ID: 1834312
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.
Brücke T; Podreka I; Angelberger P; Wenger S; Topitz A; Küfferle B; Müller C; Deecke L
J Cereb Blood Flow Metab; 1991 Mar; 11(2):220-8. PubMed ID: 1671782
[TBL] [Abstract][Full Text] [Related]
16. Loss of dopamine D2 receptors in Alzheimer's disease with parkinsonism but not Parkinson's or Alzheimer's disease.
Joyce JN; Murray AM; Hurtig HI; Gottlieb GL; Trojanowski JQ
Neuropsychopharmacology; 1998 Dec; 19(6):472-80. PubMed ID: 9803423
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, Alzheimer disease, and neurologically normal controls.
Mizukawa K; McGeer EG; McGeer PL
Mol Chem Neuropathol; 1993; 18(1-2):133-44. PubMed ID: 8466587
[TBL] [Abstract][Full Text] [Related]
18. Mapping dopamine receptors in the human brain.
Palacios JM; Camps M; Cortés R; Probst A
J Neural Transm Suppl; 1988; 27():227-35. PubMed ID: 2969952
[TBL] [Abstract][Full Text] [Related]
19. In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias.
Turjanski N; Lees AJ; Brooks DJ
Neurology; 1997 Sep; 49(3):717-23. PubMed ID: 9305330
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology.
Cortés R; Camps M; Gueye B; Probst A; Palacios JM
Brain Res; 1989 Mar; 483(1):30-8. PubMed ID: 2650806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
